A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia (CML)
NCT 05304377 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05304377 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 06092580 Brief Summary The aims of this clinical trial are (1)…
Read more arrow_forwardNCT 03212404 Brief Summary CK-301 (cosibelimab) is a fully human monoclonal antibody…
Read more arrow_forwardNCT 06179511 Brief Summary This is a modular, multicentre, open-label, Phase…
Read more arrow_forwardNCT 04581512 Brief Summary A research study looking at a new treatment…
Read more arrow_forward